The Facelift That Doesn't Look Like a Facelift
Inside the Stemcell Therapy Breakthrough of Dr.
In independent studies involving 85 patients, investigators documented significant improvements in skin complexion, tissue quality, firmness, elasticity, and structural integrity. Regenerative biomarkers showed 70% to 200% improvement compared to older non-surgical technologies. These changes were not purely aesthetic; they reflected measurable biological repair and renewal.
A broader five-year retrospective analysis of 520 patients treated at
Patients with prior surgical procedures responded as well as those who had never undergone surgery, positioning the protocol as a long-term biological partner to surgery rather than a replacement. The defining feature was the timeline: results accumulated slowly, with the face evolving naturally.
Neustem™ functions without adding volume or altering contours. It does not rely on fillers or scaffolds, but instead activates regenerative signaling pathways that strengthen dermal and subcutaneous tissues and improve cellular communication responsible for elasticity and resilience. Patients report looking "restored" rather than "done."
Coolaser®, paired with Neustem™, refines the skin surface with precision and minimal trauma, improving texture, tone, and clarity while preserving deeper regenerative processes.
Together, the protocol defines a new category in aesthetic medicine. In an era concerned with overcorrection and artificial results, regenerative aesthetics offers a different promise: not to erase age, but to restore biological function. As
Media Contact
3054905911
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/the-facelift-that-doesnt-look-like-a-facelift-302672003.html
SOURCE Dr.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 2026 World Robot Conference: Zoomlion Showcases Industrial Embodied Intelligence
- Next Level Performance Marks 50 Years of Impact with HOPE Week
- Hofseth BioCare ASA: SECOND QUARTER 2026 FINANCIAL REPORT
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share